Elixir Botanica is the Asia Pacific distributor for CanPrev and Orange Naturals products.

Cyto-Matrix Ginkgo Biloba (60 capsules)



NPN: 80108724
A highly potent extract of Ginkgo biloba, designed to enhance memory and cognitive function through its ability to improve blood flow. Sustainably sourced, traceable, and GMO-free.

  • 120mg (50:1 extract; Dried Herb Equivalent [DHE] 6000mg) of Ginkgo biloba leaf extract per vegetable capsule, standardized to contain a minimum of 24% ginkgo flavone glycosides and 6% terpene lactones
  • Designed to enhance memory and cognitive function through its ability to upregulate nitrioxide pathways and improve blood flow
  • A part of the Herbal Matrix series, containing sustainably sourced, traceable and GMO-free herbs with potent therapeutic properties

Vegan. GMO, gluten, soy and dairy free.

Description


Ginkgo biloba is a well-known herb that has traditionally been used as a memory aid and to improve overall cognitive function. Dozens of research trials have confirmed that Ginkgo biloba is capable of improving cognitive parameters such as reaction time, memory, processing speed and accuracy, short term memory and facial recognition.

Ginkgo biloba’s positive effects on the nervous system are primarily attributed to its ability to upregulate nitric oxide pathways and improve blood flow into the brain, thereby increasing oxygen delivery, nutrient delivery and the elimination of toxic byproducts to the central nervous system.

Ginkgo biloba’s beneficial effects on the human body extend beyond memory and cognition. Clinical trials have also found that the herb may be capable of improving symptoms of intermittent claudication, premenstrual symptoms, acute mountain sickness, mood in individuals with cerebral injury, ocular blood flow, and sleep quality in those with mood disorders. Individuals with high-risk of cardiovascular events appear to benefit from Ginkgo biloba supplementation because of its additional ability to prevent LDL oxidation.

Ginkgo Biloba from Cyto-Matrix contains 120mg of Ginkgo biloba leaf extract per vegetable capsule, standardized to contain a minimum of 24% ginkgo flavone glycosides and 6% terpene lactones. Gingko Biloba is also guaranteed to be low in ginkgolic acid, a compound found to be neurotoxic, genotoxic and allergenic when ingested in higher amounts. Each bottle of Ginkgo Biloba contains 60 vegetable capsules.

Ginkgo Biloba is a part of the Cyto-Matrix Herbal Matrix Series, containing sustainably sourced, traceable and GMO free herbs with potent therapeutic properties. Each herb is extracted and tested to ensure the standardization of active ingredients, ultimately leading to efficacious, predictable and reliable products. The Cyto-Matrix Herbal Matrix Series of herbal extracts is beneficial for both the health of individuals, and also the health of our planet and future generations.

Medicinal Ingredients



Ingredient Amount
Ginkgo biloba extract (leaf, Ginkgo biloba) 5.4% terpene lactones, 22% flavonoid glycosides, 50:1, DHE 6000mg 120mg
Euromed Phytoproof *PhytoProof® is a registered trademark of Euromed USA, Inc
Unit of Measure above: Each capsule


Non-Medicinal Ingredients

Vegetable-grade magnesium stearate, brown rice flour, microcrystalline cellulose. Capsule: hypromellose.


Directions & Cautions

Indications: Helps to enhance cognitive function and memory in adults. Helps to support peripheral circulation.

Directions for Use: Adults - Take 1 capsule, 1-2 times per day or as directed by a healthcare professional.

Duration of use: Consult a healthcare professional for use beyond 4 weeks.

Cautions: Do not use if safety seal is broken. Consult a healthcare professional prior to use if you are pregnant or breastfeeding. Consult a healthcare professional prior to use if you are taking medications for diabetes, high blood pressure or seizures.

Contraindications: Do not use this product if you are taking health products that affect blood coagulation as this may increase the risk of spontaneous bleeding.


the above information is updated as of 21 May 2024